Arcano ha actuado como asesor financiero exclusivo de Magnum Industrial Partners y su participada Agronova Biotech, en la compra de Mundeco, referente nacional en el cultivo de microalgas para la fabr...
The financing round was led by Sofinnova Partners, a leading European venture capital firm in life sciences, and Asabys, a venture capital firm based in Barcelona and specialized in the healthcare sec...
Tagworks Pharmaceuticals, the pioneer of Click-to-Release chemistry designed to deliver more effective and safer systemic therapies, today announced a $65 million Series A financing led by Ysios Capit...
The transaction was led by the venture capital firm Invivo Capital, with the participation of the current investors, the Josep Carreras Leukemia Foundation and the Centre for Technological Development...
Stirling Square Capital Partners has announced that its portfolio company Sustainable Agro Solutions has acquired Biovert, a developer and producer of bio-stimulants, biocontrol and specialty plant nu...
Orikine Bio, a biotech company developing a novel proprietary platform for cytokine-based therapies for autoimmune and inflammatory diseases, announces today the successful closing of a €5.5m seed f...
Moira Capital, firma de inversión de capital privado, y la gestora vasca Inbergune, han adquirido el 30% de CIMICO, compañía que está liderando la innovación en soluciones biotecnológicas para e...
Tras la lucha contra el Covid-19, las farmacéuticas se enfrentan a una nueva normalidad repleta de oportunidades y desafíos, y el mercado está listo para aprovecharlas. El reciente anuncio de que E...
The Basque Government, through Gestión de Capital Riesgo del País Vasco SGEIC, has formalized its entry into the biotech company Patia Diabetes with the aim of promoting research and development of ...
Health in Code, a leading clinical genetic diagnostics company in Spain and an Alantra Private Equity portfolio company, has acquired genetic analysis laboratory Genologica to consolidate its leading ...
The Catalan biopharmaceutical company AbilityPharma, focused on the development of innovative oral anticancer compounds, undertakes a collective investment campaign of up to 2 million on the Capital C...
Asabys Partners led the round through its new fund Sabadell Asabys II and was joined by Thuja Capital and founding investor Sofinnova Partners. Gradient was established in 2020 through a €3.5m seed ...